BULLFROG AI HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
BULLFROG AI HOLDINGS, INC. (BFRG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 37.50 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-05-14
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 37.50K shares, a 82.27% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 10.00K shares, a 58.33% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 45.00K shares, a 18.18% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 266.50K shares, a 32.02% decline from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 392.00K shares, a 14.50% decline from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 458.50K shares.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 29.29K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-03-31 | 37.50K shares 10-Q · filed 2026-05-14 | 47.50K shares derived: sum of 2 quarters · filed 2026-05-14 | 92.50K shares derived: sum of 3 quarters · filed 2026-05-14 | 92.50K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 55.00K shares derived: sum of 2 quarters · filed 2026-03-19 | 55.00K shares derived: sum of 3 quarters · filed 2026-03-19 | 266.50K shares 10-K · filed 2026-03-19 |
| 2025-09-30 | 45.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 45.00K shares derived: sum of 2 quarters · filed 2025-11-14 | 256.50K shares 10-Q · filed 2025-11-14 | 280.50K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 211.50K shares 10-Q · filed 2025-08-13 | 235.50K shares derived: sum of 3 quarters · filed 2026-05-14 | 290.50K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | 211.50K shares 10-Q · filed 2026-05-14 | 235.50K shares derived: sum of 2 quarters · filed 2026-05-14 | 290.50K shares derived: sum of 3 quarters · filed 2026-05-14 | 304.50K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 24.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 79.00K shares derived: sum of 2 quarters · filed 2026-03-19 | 93.00K shares derived: sum of 3 quarters · filed 2026-03-19 | 392.00K shares 10-K · filed 2026-03-19 |
| 2024-09-30 | 55.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 69.00K shares derived: sum of 2 quarters · filed 2025-11-14 | 368.00K shares 10-Q · filed 2025-11-14 | 388.00K shares derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | 14.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 313.00K shares 10-Q · filed 2025-08-13 | 333.00K shares derived: sum of 3 quarters · filed 2025-08-13 | 392.00K shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | 299.00K shares 10-Q · filed 2025-05-13 | 319.00K shares derived: sum of 2 quarters · filed 2025-05-13 | 378.00K shares derived: sum of 3 quarters · filed 2025-05-13 | 573.00K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 20.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | 79.00K shares derived: sum of 2 quarters · filed 2025-03-14 | 274.00K shares derived: sum of 3 quarters · filed 2025-03-14 | 458.50K shares 10-K · filed 2025-03-14 |
| 2023-09-30 | 59.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 254.00K shares derived: sum of 2 quarters · filed 2024-11-08 | 438.50K shares 10-Q · filed 2024-11-08 | |
| 2023-06-30 | 195.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 379.50K shares 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | 184.50K shares 10-Q · filed 2024-05-10 | |||
| 2021-12-31 | 29.29K shares 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |